Skip to Main Content

Advertisement

Skip Nav Destination

FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy

Blood (2018) 131 (2): 226–235.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement